Inhibition of EZH1 and EZH2 Restores Chemosensitivity of Leukemia Stem Cells in Acute Myeloid Leukemia By Recruitment of Quiescent AML Stem/Progenitor Cells

被引：4
|
作者：
Chang, Kyung Hee
Alaniz, Zoe
Nishida, Yuki
Dos Santos, Cedric E.
Slosberg, Eric
Daver, Naval
Andreeff, Michael
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-142071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
    Xun Jin
    Leo J Y Kim
    Qiulian Wu
    Lisa C Wallace
    Briana C Prager
    Tanwarat Sanvoranart
    Ryan C Gimple
    Xiuxing Wang
    Stephen C Mack
    Tyler E Miller
    Ping Huang
    Claudia L Valentim
    Qi-gang Zhou
    Jill S Barnholtz-Sloan
    Shideng Bao
    Andrew E Sloan
    Jeremy N Rich
    Nature Medicine, 2017, 23 : 1352 - 1361
  • [32] Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
    Jin, Xun
    Kim, Leo J. Y.
    Wu, Qiulian
    Wallace, Lisa C.
    Prager, Briana C.
    Sanvoranart, Tanwarat
    Gimple, Ryan C.
    Wang, Xiuxing
    Mack, Stephen C.
    Miller, Tyler E.
    Huang, Ping
    Valentim, Claudia L.
    Zhou, Qi-gang
    Barnholtz-Sloan, Jill S.
    Bao, Shideng
    Sloan, Andrew E.
    Rich, Jeremy N.
    NATURE MEDICINE, 2017, 23 (11) : 1352 - +
  • [33] Cancer stem cell-targeted therapy for hematological and sold cancers by inhibition of EZH1/EZH2 and mutant IDH1
    Kitabayashi, Issay
    CANCER SCIENCE, 2018, 109 : 345 - 345
  • [34] TARGETING GLIOMA STEM CELLS THROUGH COMBINED BMI1 AND EZH2 INHIBITION
    Jin, Xun
    Kim, Leo
    Wu, Qiulian
    Wallace, Lisa C.
    Prager, Briana
    Sanvoranart, Tanwarat
    Gimple, Ryan
    Mack, Stephen
    Miller, Tyler E.
    Huang, Ping
    Barnholtz-Sloan, Jill
    Bao, Shideng
    Sloan, Andrew
    Rich, Jeremy
    NEURO-ONCOLOGY, 2017, 19 : 80 - 80
  • [35] RETRACTED: Clinical Significance of EZH2 in Acute Myeloid Leukemia (Retracted Article)
    Jiao, Weiyun
    Liu, Yuanyuan
    Bao, Yangyi
    COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
  • [36] Inhibition of EZH2/EZH1 by UNC1999 Enhances the Potency of the EGFR Inhibitor Gefitinib in Colon Cancer Cells
    Katona, Bryson
    Liu, Yuanyuan
    Ma, Anqi
    Jin, Jian
    Hua, Xianxin
    GASTROENTEROLOGY, 2014, 146 (05) : S626 - S626
  • [37] Higher EZH2 expression is associated with extramedullary infiltration in acute myeloid leukemia
    Zhu, Qiuhua
    Zhang, Lingxiu
    Li, Xiaodong
    Chen, Fang
    Jiang, Ling
    Yu, Guopan
    Wang, Zhixiang
    Yin, Changxin
    Jiang, Xuejie
    Zhong, Qingxiu
    Zhou, Hongsheng
    Ding, Bingjie
    Wang, Chunli
    Meng, Fanyi
    TUMOR BIOLOGY, 2016, 37 (08) : 11409 - 11420
  • [38] EZH2, new diagnosis and prognosis marker in acute myeloid leukemia patients
    Mechaal, Amal
    Menif, Samia
    Abbes, Salem
    Safra, Ines
    ADVANCES IN MEDICAL SCIENCES, 2019, 64 (02): : 395 - 401
  • [39] Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia
    Tanaka, Satomi
    Miyagi, Satoru
    Sashida, Goro
    Chiba, Tetsuhiro
    Yuan, Jin
    Mochizuki-Kashio, Makiko
    Suzuki, Yutaka
    Sugano, Sumio
    Nakaseko, Chiaki
    Yokote, Koutaro
    Koseki, Haruhiko
    Iwama, Atsushi
    BLOOD, 2012, 120 (05) : 1107 - 1117
  • [40] Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
    Ding, Yahui
    Gao, Huier
    Zhang, Yu
    Li, Ye
    Vasdev, Neil
    Gao, Yingdai
    Chen, Yue
    Zhang, Quan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9 : 1 - 12
12345